O'Dell Group, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
O'Dell Group, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,337
-74.2%
10,1420.0%0.00%
-100.0%
Q2 2023$5,173
-19.0%
10,1420.0%0.00%
-50.0%
Q1 2023$6,390
-2.9%
10,1420.0%0.00%0.0%
Q4 2022$6,583
-61.3%
10,1420.0%0.00%
-66.7%
Q3 2022$17,000
-34.6%
10,142
-50.0%
0.01%
+20.0%
Q2 2022$26,000
+271.4%
20,284
+100.0%
0.01%
+150.0%
Q1 2022$7,000
-36.4%
10,1420.0%0.00%
-33.3%
Q4 2021$11,000
-38.9%
10,1420.0%0.00%
-50.0%
Q3 2021$18,000
-33.3%
10,1420.0%0.01%
-33.3%
Q2 2021$27,000
-27.0%
10,1420.0%0.01%
-30.8%
Q1 2021$37,000
+42.3%
10,1420.0%0.01%
+30.0%
Q4 2020$26,000
-45.8%
10,1420.0%0.01%
-58.3%
Q4 2019$48,000
+11.6%
10,1420.0%0.02%0.0%
Q3 2019$43,000
-27.1%
10,1420.0%0.02%
-33.3%
Q2 2019$59,000
+51.3%
10,1420.0%0.04%
+44.0%
Q1 2019$39,000
+105.3%
10,1420.0%0.02%
+78.6%
Q4 2018$19,000
-40.6%
10,1420.0%0.01%
-33.3%
Q3 2018$32,000
+3.2%
10,1420.0%0.02%0.0%
Q2 2018$31,000
-22.5%
10,1420.0%0.02%
-27.6%
Q1 2018$40,000
-4.8%
10,1420.0%0.03%
-6.5%
Q4 2017$42,000
-32.3%
10,1420.0%0.03%
-35.4%
Q3 2017$62,000
-1.6%
10,1420.0%0.05%
-9.4%
Q2 2017$63,000
-1.6%
10,1420.0%0.05%
-7.0%
Q1 2017$64,000
+18.5%
10,1420.0%0.06%
+9.6%
Q4 2016$54,00010,1420.05%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 12,546,493$22,835,0001.71%
MSD Partners, L.P. 15,151,516$27,576,0000.84%
MSD Partners, L.P. 7,575,758$13,788,0000.42%
CHIRON CAPITAL MANAGEMENT, LLC 198,002$360,0000.26%
Avidity Partners Management LP 3,000,000$5,460,0000.12%
Old West Investment Management, LLC 211,513$384,0000.10%
MAGNOLIA CAPITAL ADVISORS LLC 103,239$188,0000.07%
Virtus ETF Advisers LLC 72,060$131,0000.06%
ACT WEALTH MANAGEMENT, LLC 34,454$91,0000.06%
Allred Capital Management, LLC 53,000$96,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders